FDA's Assessment Of Bisphenol A 'Inadequate': Panel
A panel advising the U.S. Food and Drug Administration on the safety of bisphenol A says the agency's draft assessment of the controversial chemical was "inadequate" and failed to articulate "reasonable...To view the full article, register now.
Already a subscriber? Click here to view full article